14,033
Total Claims
$2.0M
Drug Cost
1,634
Beneficiaries
$1,225
Cost/Patient
Peer Comparison vs. 4,479 Interventional Cardiology providers
+16%
Cost per patient vs peers
$1,225 vs $1,054 avg
-15%
Brand preference vs peers
11.2% vs 13.1% avg
Brand vs Generic
89% generic
Brand: 1,570 claims · $1.6M
Generic: 12,463 claims · $366K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 732 | $894K |
| Sacubitril/Valsartan | 236 | $295K |
| Rivaroxaban | 119 | $158K |
| Ticagrelor | 96 | $79K |
| Alirocumab | 67 | $54K |
| Evolocumab | 46 | $50K |
| Ranolazine | 317 | $40K |
| Clopidogrel Bisulfate | 1,184 | $26K |
| Empagliflozin | 31 | $26K |
| Dronedarone Hcl | 12 | $23K |
| Isosorbide Mononitrate | 887 | $19K |
| Atorvastatin Calcium | 1,010 | $19K |
| Metoprolol Succinate | 780 | $19K |
| Pitavastatin Calcium | 18 | $18K |
| Clonidine | 75 | $17K |
Prescribing Profile
78
Unique Drugs
$1.4M
Patient Profile
77
Avg Age
49%
Female
1.65
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About